Medline Inc. (MDLN)

NASDAQ: MDLN · Real-Time Price · USD

35.51

+0.53 (1.52%)

Sep 30, 2026, 11:22 AM EDT - Market open

Medline Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	29,939	28,432	25,507	23,231	21,448
Revenue Growth	12.12%	11.47%	9.80%	8.31%	-
Gross Profit	7,513	7,518	6,976	5,885	5,217
Operating Income	1,494	2,179	2,148	1,411	861
Net Income	701	1,159	1,200	234	-25
Earnings Per Share	0.80	1.43	0.07	0.01	-
EPS Growth	998.36%	1982.77%	413.80%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Front Line Care	6,666	6,514	6,088	5,845	5,709
Surgical Solutions	6,404	6,166	5,471	4,931	4,446
Laboratory and Diagnostics	1,069	1,040	956	837	844
Supply Chain Solutions	15,800	14,712	12,992	11,618	10,449
Revenue (Total)	29,939	28,432	25,507	23,231	21,448

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	2,700	1,975	278	1,691	-
Total Debt	12,640	13,013	16,899	16,832	-
Net Cash (Debt)	-9,940	-11,038	-16,621	-15,141	-
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-11.33	-13.63	-0.95	-0.87	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	1,992	1,744	1,769	1,685	187
Capital Expenditures	-446	-480	-364	-285	-254
Free Cash Flow	1,546	1,264	1,405	1,400	-67
Free Cash Flow Growth	41.97%	-10.04%	0.36%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	25.09%	26.44%	27.35%	25.33%	24.32%
Operating Margin	4.99%	7.66%	8.42%	6.07%	4.01%
Pretax Margin	3.60%	4.39%	4.88%	1.14%	0.05%
Profit Margin	2.34%	4.08%	4.71%	1.01%	-0.12%
FCF Margin	5.16%	4.45%	5.51%	6.03%	-0.31%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	44.68	30.16	-	-	-
P/FCF Ratio	29.75	27.65	-	-	-
PS Ratio	1.54	1.23	-	-	-